Tokyo, Aug. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058725) titled 'Effect of rosmarinic acid intake on sleep : systematic review' on Aug. 7.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Sankyo Co.,Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate effects of rosmarinic acid intake on sleep in healthy adults.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1)Trial with following the PICOS
P:Healthy adults
I:Oral intake of foods with rosmarinic acid
C:Oral intake of placebo foods
O:Sleep quality measures
S:Randamized Placebo-controlled Trial
2)Original paper published in peer-reviewed journals
Key exclusion criteria - 1)Participants with sleep disorder
2)Clinical trials in which factors other than rosmarinic acid intake may have influenced the outcomes
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 05 Day
Anticipated trial start date - 2025 Year 08 Month 08 Day
Last follow-up date - 2025 Year 08 Month 25 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067151
Disclaimer: Curated by HT Syndication.
